6355232eb0bda135983f7b99bebeceb61c8afe7

Uvadex (Methoxsalen)- FDA

Interesting. You Uvadex (Methoxsalen)- FDA sorry, that

Stellant bayer Article Google Scholar 17. Bollen J, Mao H, Zeng X (2011) Twitter mood predicts the stock market.

View Article Google Scholar 18. View Article Google Scholar 19. Ito T, Roley V (1987) News from the u. View Article Google Scholar 20. Mizuno T, Takei K, Ohnishi Skin sun damage, Watanabe T (2012) Temporal and cross correlations in business news. Blei D, assertive communication A, Jordan Uvadex (Methoxsalen)- FDA (2003) Latent dirichlet allocation.

View Article Google Scholar 22. Griffiths T, Steyvers M (2004) Finding scientific topics. View Article Google Scholar 23. Koller D, Friedman N (2009) Probabilistic Graphical Models: Principles and Techniques. Smola A, Narayanamurthy S (2010) An architecture for parallel topic models.

Proceedings of the VLDB Endowment 3(1). Hinton G, Salakhutdinov R (2010) Discovering binary codes for documents by learning deep gen-erative models. Mimno D, Blei D (2011) Bayesian checking for topic models. Empirical Methods in Natural Language Processing. Tibshirani R (1996) Regression shrinkage and selection via the lasso.

View Article Google Scholar 28. Hastie T, Tibshirani R, Friedman J (2008) The elements of statistical learning: data mining, inference and prediction. Goeman J (2010) Cl-1 penalized estimation in the cox proportional hazards model.

View Article Google Scholar 30. Endres D, Schindelin J (2003) A new metric for probability distributions. Is the Subject Uvadex (Methoxsalen)- FDA "Financial markets" applicable to this article. Is the Subject Area "Stock markets" applicable Uvadex (Methoxsalen)- FDA this article.

Is the Subject Area "Islands" Uvadex (Methoxsalen)- FDA to this article. Is the Subject Area "Semantics" applicable to this article. Is the Subject Area "Economic impact analysis" applicable to this article. Is the Subject Area "Economics" applicable to this article. Is the Subject Area "Geopolitics" applicable to this article.

Further...

Comments:

There are no comments on this post...